We are live on
!
Find out more
LP
LMR Partners Portfolio holdings
AUM
$45.4B
1-Year Est. Return
60.68%
This Fund
S&P 500
This Quarter
Est. Return
+6.09%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$9.01B
AUM Growth
+$2.56B
(+40%)
Cap. Flow
+$1.88B
Cap. Flow
% of AUM
20.91%
Top 10 Holdings %
Top 10 Hldgs %
32.68%
Holding
1,271
New
274
Increased
124
Reduced
87
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$71.4M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$50.2M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$50.2M |
| 4 |
MAXN
Maxeon Solar Technologies
MAXN
|
+$48.8M |
| 5 |
Biogen
BIIB
|
+$41.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$96.4M |
| 2 |
Alibaba
BABA
|
+$57.5M |
| 3 |
SJR
Shaw Communications Inc.
SJR
|
+$43.2M |
| 4 |
American Express
AXP
|
+$42.8M |
| 5 |
KraneShares CSI China Internet ETF
KWEB
|
+$40.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.28% |
| 2 | Technology | 7.66% |
| 3 | Healthcare | 5.37% |
| 4 | Energy | 3.3% |
| 5 | Utilities | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
Invesco QQQ Trust
QQQ
$455B
| $792M | 8.79% |
+2,142,800
| New | +$721M |
|
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $649M | 7.2% |
+1,463,000
| New | +$614M |
|
3
CALL
Apple
AAPL
$4.89T
| $533M | 5.91% |
+2,746,700
| New | +$479M |
|
|
4
PUT
Apple
AAPL
$4.89T
| $229M | 2.54% |
+1,178,700
| New | +$205M |
|
5
PUT
iShares Russell 2000 ETF
IWM
$80.9B
| $215M | 2.39% |
+1,150,000
| New | +$205M |
|
|
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $117M | 1.3% |
1,139,139
+332,933
| +41% | +$35.1M |
|
|
7
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $101M | 1.12% |
+227,000
| New | +$95.3M |
|
|
8
CALL
iShares Russell 2000 ETF
IWM
$80.9B
| $93.8M | 1.04% |
+501,000
| New | +$89.3M |
|
9
PUT
Carnival Corporation Ltd
CCL
$36.1B
| $87.6M | 0.97% |
4,650,000
+250,000
| +6% | +$2.92M |
|
|
ATVI
10
DELISTED
Activision Blizzard
ATVI
| $86.1M | 0.96% |
1,020,851
+620,220
| +155% | +$50.2M |
|
11
PUT
Eli Lilly
LLY
$1.07T
| $84.8M | 0.94% |
+180,800
| New | +$75.8M |
|
12
NVIDIA
NVDA
$5.01T
| $83.2M | 0.92% |
1,966,930
-460,750
| -19% | -$15.3M |
|
13
LPL Financial
LPLA
$26.3B
| $82.4M | 0.91% |
378,991
+116,129
| +44% | +$23.3M |
|
|
ISEE
14
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $79.6M | 0.88% |
+2,023,659
| New | +$71.4M |
|
15
PUT
Tesla
TSLA
$1.24T
| $78.5M | 0.87% |
+300,000
| New | +$60M |
|
16
PUT
TripAdvisor
TRIP
$1.59B
| $76.9M | 0.85% |
4,662,400
+473,100
| +11% | +$8.01M |
|
|
17
CALL
Invesco QQQ Trust
QQQ
$455B
| $73.9M | 0.82% |
+200,000
| New | +$67.3M |
|
18
PUT
State Street Technology Select Sector SPDR ETF
XLK
$115B
| $73.7M | 0.82% |
+847,600
| New | +$66.8M |
|
|
ATVI
19
CALL
DELISTED
Activision Blizzard
ATVI
| $71.8M | 0.8% |
+851,400
| New | +$68.9M |
|
20
AstraZeneca
AZN
$263B
| $70M | 0.78% |
488,718
+181,304
| +59% | +$26.7M |
|
|
21
PUT
Biogen
BIIB
$29.9B
| $65.2M | 0.72% |
+228,800
| New | +$68.1M |
|
22
CALL
VanEck Semiconductor ETF
SMH
$67.6B
| $63.9M | 0.71% |
+420,000
| New | +$56.8M |
|
23
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $63.2M | 0.7% |
+760,200
| New | +$63.6M |
|
24
Blackrock
BLK
$164B
| $61.2M | 0.68% |
88,533
+17,106
| +24% | +$11.5M |
|
25
PUT
Norwegian Cruise Line
NCLH
$8.89B
| $61M | 0.68% |
2,800,000
| – | – |
|
Similar funds
AS
TI
LMR Partners's Q2 2023 Portfolio in Review
As of Q2 2023, LMR Partners held 1,271 positions worth $9.01B, up 40% from $6.45B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
LMR Partners deployed $1.88B of net new capital in Q2 2023, opening 274 new positions and adding to 124 existing holdings. Its largest new stake was IVERIC bio, Inc. Common Stock: 2,023,659 shares worth $79.6M.
By sector, the portfolio is most concentrated in Financials at 8.3% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was SPDR Gold Trust, an estimated $96.4M trimmed.
- LMR Partners's largest Q2 2023 buy was IVERIC bio, Inc. Common Stock: 2,023,659 shares worth $79.6M.
- LMR Partners added most to Activision Blizzard in Q2 2023, an estimated $50.2M increase.
- LMR Partners's biggest Q2 2023 reduction was SPDR Gold Trust, cutting an estimated $96.4M.
- LMR Partners fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $43.2M.
- LMR Partners's ten largest holdings make up 33% of its $9.01B portfolio in Q2 2023.
- LMR Partners opened 274 new positions and closed 392 in Q2 2023.
- LMR Partners's portfolio value rose 40% quarter-over-quarter to $9.01B.
Based on LMR Partners's 13F filing for Q2 2023, filed 14 Aug 2023.